Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization

Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced ...

What made Harvard get softer on its students

Campus battles over DEI and free speech are part of a much larger change in philosophy that took hold over decades. Will the ...
Packaging News

Renaissance, Biome partner on renewable bioplastics

Renaissance BioScience and Biome Bioplastics are working together on a two-year Canada–UK project to develop renewable ...
TMCnet

Vascular Perfusion Solutions Announces Collaboration with Wyss Institute at Harvard to Advance Biostasis Compounds for Organ Preservation

About VPS: Vascular Perfusion Solutions (VPS) is developing the VP.S ENCORE ® platform, a simple and portable system designed to preserve donor hearts and other organs for extended durations. By ...